Viewing StudyNCT03659136

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 12:53 PM
Study NCT ID: NCT03659136
Status: COMPLETED
Last Update Posted: 2024-07-10
First Post: 2018-09-03
Brief Title: The XENERA 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
Sponsor: Boehringer Ingelheim
Organization: Boehringer Ingelheim
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Breast Neoplasms
Keywords: